Graph Neural Networks (GNNs) for Molecules vs. Convolutional Neural Networks (CNNs) for Crystals

Graph Neural Networks (GNNs) excel at modeling molecules because they directly represent atoms as nodes and chemical bonds as edges. This explicit encoding of connectivity allows GNNs like SchNet, DimeNet++, or GemNet to learn rich, structure-aware representations, leading to state-of-the-art accuracy for predicting molecular properties such as solubility or drug-likeness. For example, on the QM9 quantum chemistry benchmark, GNNs can achieve mean absolute errors below 1 kcal/mol for atomization energy predictions, a task where spatial relationships are paramount.

Convolutional Neural Networks (CNNs) and Crystal Graph CNNs (CGCNNs) take a different approach by operating on the periodic, grid-like structure of crystals. Frameworks like CGCNN or MEGNet treat the crystal as a graph of atoms within a defined neighbor radius, applying convolutions to capture local atomic environments. This results in a trade-off: while highly effective for ordered, repeating lattice structures—achieving >90% accuracy in predicting formation energies on datasets like the Materials Project—they can be less intuitive for modeling discrete, non-periodic molecular systems where explicit bond orders matter.

The key trade-off is between structural fidelity and computational universality. If your priority is discrete molecular systems with explicit bonds (e.g., organic chemistry, drug candidates), choose GNNs for their native representation of connectivity. If you prioritize periodic crystalline materials (e.g., perovskites, battery cathodes), choose CNNs/CGCNNs for their efficient handling of symmetry and infinite lattice patterns. This architectural decision directly impacts downstream tasks in our pillar on Scientific Discovery and Self-Driving Labs (SDL), such as autonomous experiment planning and the use of unified materials representations.

Graph Neural Networks (GNNs) excel at modeling discrete, non-periodic molecular structures because they operate directly on graph representations, capturing atomic bonds and spatial relationships with high fidelity. For example, models like SchNet and DimeNet++ achieve state-of-the-art accuracy on quantum chemical property predictions (e.g., atomization energy within ~1 kcal/mol on the QM9 benchmark) by learning from the inherent connectivity of atoms. This makes them the undisputed choice for drug discovery and organic molecule design, where bond types and functional groups are critical.

Convolutional Neural Networks (CNNs), particularly Crystal Graph CNNs (CGCNNs), take a fundamentally different approach by treating the crystal's periodic lattice as a graph of atoms within a local neighborhood. This strategy results in a trade-off: while excellent for capturing the symmetry and infinite repeating patterns of inorganic crystals (e.g., perovskites, zeolites), they can struggle with the explicit, directional bond information that GNNs handle naturally. The computational cost for CGCNNs is often lower per structure than for 3D-equivariant GNNs when processing large databases like the Materials Project.

The key trade-off is structural representation versus computational symmetry. If your priority is discrete, bonded systems like organic molecules, polymers, or proteins, choose GNNs. Their architecture is inherently matched to the problem, leading to superior predictive accuracy for properties like solubility or binding affinity. If you prioritize periodic, solid-state materials like battery electrodes or catalysts, choose CNNs/CGCNNs. Their ability to efficiently encode crystal symmetry and work with standardized crystallographic data is paramount. For a deeper dive into AI architectures for scientific discovery, explore our guide on Physics-Informed Neural Networks (PINNs) vs. Pure Data-Driven Models and the strategic use of Multi-Fidelity Modeling to optimize data efficiency.